结合GLIM表型标准可以改善癌症相关营养不良的生存预测
María Galindo Gallardo1, Beatriz Rodríguez Jiménez1, Nicolás Gallego Pena2
1Department of Endocrinology and Nutrition, Virgen Macarena University Hospital, Seville, Spain.
Nutrition (Burbank, Los Angeles County, Calif.)
|October 14, 2025
概括
限制性全球营养不良领导倡议 (GLIM) 标准,特别是使用无脂肪质量指数 (FFMI) 和尾骨肌质量指数 (ASMI),更好地预测癌症患者的死亡率. 这些发现有助于对瘤病患者的营养评估.
科学领域:
- 临床营养学 临床营养学
- 在瘤学瘤学.
- 老年病的医生 老年病的医生
背景情况:
- 准确的营养评估对瘤学患者至关重要.
- 全球营养不良领导倡议 (GLIM) 提供了诊断营养不良的表型标准.
- 在瘤学中GLIM标准的诊断协议和预后价值需要进一步评估.
研究的目的:
- 在瘤病患者中评估GLIM表型标准之间的诊断一致性.
- 用单个和组合GLIM标准比较营养不良患病率估计.
- 评估GLIM标准对该人口死亡率的预后价值.
主要方法:
- 对209名成年瘤病患者进行了回顾性队列研究.
- 使用FFMI,ASMI和手握强度等工具评估GLIM表型标准.
- 分析诊断一致性 (卡帕,ICC) 和死亡率相关性 (Cox回归).
主要成果:
- 在大多数表型标准中达成较低的协议 (卡帕<0.4),除了FFMI和ASMI (ICC=0.847).
- 与包容性相比,限制性GLIM策略与死亡率的相关性更强.
- BMI,体重减轻,FFMI和ASMI的组合显示出最高的预后值 (HR 2.98).
结论:
- 结合多个表型标准的基于GLIM的限制性策略提高了瘤学中的死亡率预测.
- 无脂肪质量指数 (FFMI) 和附骨肌质量指数 (ASMI) 是关键的强有力的指标.
- 这些发现支持针对癌症患者的精细营养评估方案.
更多相关视频
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
2.2K
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
18.6K
相关概念视频
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Cancer Survival Analysis
645
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
645
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
